A ge-related macular degeneration (AMD) is the leading cause of irreversible visual impairment in persons aged 60 y and older in Western countries (1) . The pathogenesis of AMD is complex and not well established. Chronic local inflammation from persistent infection was recently identified as a candidate etiology for AMD. Choroidal neovascularization (CNV), the hallmark of wet AMD, was shown to be dependent on inflammatory cytokines, as well as inflammatory signals. Genetic studies also demonstrated strong associations between AMD and several gene variants in genes coding for inflammatory mediators and complement proteins (1) (2) (3) .
CNV consists of new blood vessel growth from the choroid extending into the subretinal space. These immature vessels easily permit subretinal bleeding or extravascular leakage of blood components, causing injury to the retina. Vascular endothelial growth factor (VEGF) from retinal pigment epithelium (RPE) cells and infiltrating macrophages has been considered the most important factor for CNV development (4, 5) . NKT cells, as well as inflammatory cytokines, such as IL-1b, IL-6, and TGF-b, were shown to promote CNV, whereas IL-27 suppresses it by modulating VEGF levels (6) (7) (8) (9) .
IL-17 is a major proinflammatory cytokine linked to the pathogenesis of diverse autoimmune and inflammatory diseases, such as rheumatoid arthritis (RA), psoriasis, inflammatory bowel disease, and uveitic diseases. Of note, IL-17 was shown to be proangiogenic and to induce endothelial cell invasion (10) . IL-17 has the potential to upregulate VEGF from RA synoviocytes (11) and to promote the development of microvessel structures in RA, as well as in tumor growth (12, 13) . Recently, a subset of effector Th cells, the IL-17-producing T cell (Th17), was implicated in the pathogenesis of various autoimmune diseases, including uveitis, arthritis, multiple sclerosis, psoriasis, and inflammatory bowel disease. In addition, gdT cells, as well as innate lymphoid cells (ILCs), have been implicated as IL-17-producing cells (14) . A recent study suggested that C5a promoted IL-22 and IL-17 expression from CD4 + T cells in AMD patients (15) . Intriguingly, this study found significantly increased levels of IL-22 and IL-17 in the sera of AMD patients, suggesting possible roles for IL-22 and IL-17 in the inflammation that contributes to CNV and AMD. However, the role of IL-17 and mechanism of IL-17 expression in experimental CNV have not been investigated.
In this study, using gene-disrupted mice and inoculation with Abs, we demonstrated that IL-17 is essential for the development of laser-induced CNV. We identified infiltrated gdT cells, but not Th17 cells, along with Thy-1 + ILCs as the main sources of IL-17 in the laser-treated eye. Furthermore, we found that IL-1b and highmobility group box 1 (HMGB-1), rather than IL-23, play critical roles in the infiltration of IL-17-producing cells. Moreover, IL-1b, HMGB-1, and gdT cells were shown to be essential for inducing IL-17, and suppression of these cytokines/cells was therapeutic for experimental CNV. Our study indicates that IL-17 plays a central role in CNV and could serve as a therapeutic target for AMD.
Materials and Methods

Animals
C57BL/6 (wild-type [WT]) mice, 6-10 wk of age, were purchased from CLEA (Tokyo, Japan) and were kept under specific pathogen-free conditions at Keio University. IL-17 knockout (KO) (16) and IL-23p19 KO (17) mice were described previously. RAG2 KO and TCRgd KO mice were purchased from The Jackson Laboratory (Bar Harbor, ME). TLR2 and TLR4 KO mice were provided by Dr. S. Akira (Laboratory of Host Defense, Osaka University, Osaka, Japan). All mice were on the C57BL/6 background. All animal experiments were conducted in accordance with the Association for Research in Vision and Ophthalmology Statement for the Use of Animals.
Induction and evaluation of CNV
CNV was induced by laser photocoagulation (PC) and evaluated as described previously (18) . Briefly, PC (wavelength = 532 nm, 0.1 s, spot size = 75 mm, power = 200 mW) was performed at four spots around the optic disc of one eye of each mouse. Abs and recombinant proteins were inoculated into the vitreous cavities with a microsyringe immediately after laser treatment. On day 7 after laser treatment, the mice were perfused with 1 ml PBS containing 50 mg/ml fluorescentlabeled dextran (25,000 m.w.; Sigma-Aldrich, St. Louis, MO), and the eyes were removed. The entire retina was carefully dissected from the eyecup and flat-mounted on an aqua-mount with the sclera facing downward and the choroid facing upward. The images were captured using conventional fluorescence microscopy (BZ-8000; Keyence) for CNV area measurement or confocal laser microscopy (LSM510 META; Carl Zeiss) for CNV volume measurement. The hyperfluorescent area and volume corresponding to a photocoagulation spot for each treated eye was evaluated using ImageJ software and subjected to semiquantitative analysis.
Vitreous cavity injection
rIL-17, anti-IL-17 Ab, anti-VEGFA Ab, and rIL-1ra (R&D Systems, Minneapolis, MN) were inoculated into the vitreous cavity using fine, 32-Ga needles (cat. no. 0160832) and 10-ml syringes (cat. no. 80330; both from Hamilton, Reno, NV). The tip of the needle penetrated the sclera, choroid, and retina to reach the vitreous cavity, and a maximum volume of 2 ml/injection was applied per eye. We ensured that the Ag was injected into the vitreous cavity by carefully guiding the tip of the needle under the microscope, through the flattened cornea, which was covered by a glass microscope slide. Inoculating 2 ml solution increased the intraocular pressure sufficiently to seal the retinal incision completely without bleeding or detachment. We considered the total volume of the murine eye to be 10 ml; therefore, 2 ml inoculated Ab solution was diluted five times in vivo. The concentration of each inoculating Ab/recombinant cytokine was determined according to the manufacturer's instructions so as to be sufficient for neutralization or supplementation in vivo.
Real-time RT-PCR
Total RNA was extracted from whole eyes, with the exception of the conjunctiva. Samples from two eyes were pooled to obtain a sufficient amount of mRNA for analysis. The RNA was extracted using Sepasol-RNA I Super G (Nacalai Tesque, Kyoto, Japan), according to the manufacturer's instructions. RNA was reverse transcribed to cDNA with random primers and a high-capacity cDNA reverse transcription kit (both from Applied Biosystems, Carlsbad, CA), in accordance with the manufacturer's instructions. Gene expression was examined using a Bio-Rad (Hercules, CA) iCycler Optical System and SsoFast EvaGreen Supermix. The results were normalized to HPRT levels. The primers used were as follows: 59-CAGCAGC-GATCATCCCTCAAAG-39 and 59-CAGGACCAGGATCTCTTGCTG-39 for IL-17; 59-CAGGCAGGCAGTATCACTCA-39 and 59-AGGCCACAGG-TATTTTGTCG-39 for IL-1b; 59-ACCTCCACTGCCAGCTGTGTGCTG-TC-39 and 59-TCATTTCTGCACTTCTGCATGTAGACTGTCCC-39 for RORgt; 59-TGAAGAGCTACTGTAATGATCAGTCAAC-39 and 59-AGCAAGCT-TGCAACCTTAACCA-39 for HPRT; and 59-CCATTGGTGATGTTGCA-AAG-39 and 59-CTTTTTCGCTGCATCAGGTT-39 for HMGB-1.
Immunohistochemistry
As reported previously (19) , hamster anti-mouse TCRgd (BD Biosciences, Franklin Lakes, NJ) and rabbit polyclonal anti-HMGB-1 (Abcam, Cambridge, U.K.) were used as primary Abs and incubated at 4˚C overnight. Goat anti-rabbit IgG conjugated to Alexa Fluor 488 was used as a secondary Ab and incubated at room temperature for 1 h.
Isolation of ocular-infiltrating cells and flow cytometric analysis
To examine phenotypes, ocular-infiltrating cells were prepared as described previously (5) . After PC, the eyes were enucleated, and the posterior segments of two eyes were used for FACS analysis. For intracellular cytokine staining, cells were stimulated for 4.5 h in complete medium with phorbol 12-myristate 13-acetate (50 ng/ml) and ionomycin (500 ng/ml; both from Sigma-Aldrich) in the presence of brefeldin A (eBioscience, San Diego, CA). Surface staining was then performed in the presence of Fc-blocking Abs (2.4G2), followed by intracellular staining for cytokines with a fixation and permeabilization kit (eBioscience), according to the manufacturer's instructions. All Abs were obtained from eBioscience. Data were acquired using a BD FACSAria or BD FACSCanto II and were analyzed with FlowJo software (Tree Star, Ashland, OR).
Transfer of gdT cells or CD4
+ T cells into Rag2 KO mice CD3 + T lymphocytes were prepared from the spleens and lymph nodes of WT mice by negative selection using magnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany) (typically .95% purity) (20) + TCRgd 2 cells from WT mice, purified through flow cytometry, was injected i.v. into Rag2 KO mice. Four days after cell transfer, the mice were subjected to laser treatment; 1 wk later, the eyes were enucleated for evaluation of CNV.
In vitro assay
A total of 1 3 10 5 CD3
+ CD4 2 TCRgd + T cells was cultured for 48 h with 1 ng/ml plate-bound anti-CD3 Ab (clone 145-2C11) in the presence of 0.1-10 ng/ml rIL-1b (PeproTech, London, U.K.), 1 ng/ml IL-23 (PeproTech), or 1 mg/ml HMGB-1 (Shino-Test, Tokyo, Japan). The amount of secreted IL-17 protein in the supernatants was measured using ELISA (eBioscience), according to the manufacturer's instructions.
Statistical analyses
All data are expressed as mean 6 SE and were analyzed using the Dunnett test and the independent-samples t test. The p values , 0.05 were considered statistically significant.
Results
IL-17 promotes choroidal neovascularization after laser treatment
Because a recent report (15) showed a significant increase in IL-17 levels in the sera of AMD patients, we investigated the role of IL-17 in laser-induced CNV in mice. After laser treatment to the eye, expression of Il17a mRNA significantly increased from day 3, peaked at day 4, and then gradually decreased (Fig. 1A) . To investigate the functional role of IL-17 in ocular neovascularization, Il17a-deficient (IL-17 KO) mice were examined. On day 7 after laser treatment, CNV was visualized by the perfusion of fluorescent-labeled dextran, and the green neovascularized areas were measured on choroidal flat mounts. Compared with control mice, IL-17 KO mice exhibited significantly smaller areas of CNV (Fig. 1B) . In contrast, areas of CNV were significantly larger in WT mice inoculated with rIL-17 than in untreated WT mice (Fig. 1C) . These data indicate that IL-17 promotes CNV development.
We investigated the relationship between IL-17 and VEGF. Unexpectedly, WT and IL-17 KO mice had similar VEGF mRNA levels in their injured eyes (Fig. 1D) . Next, we compared the effect of depletion of VEGF and IL-17 on CNV development using Abs. When anti-IL-17 Ab was inoculated into the vitreous cavity, CNV volume was reduced (Fig. 1E, 1F ). The suppressive effect of anti-IL-17 Ab on CNV volume and area was similar to that of anti-VEGF FIGURE 1. Angiogenic activity of IL-17 in CNV. (A)Total RNA was extracted from the eyes of WT mice on the indicated days after laser treatment (n = 3). Il17a mRNA levels were normalized to HPRT levels in each sample. (B) On day 7 after laser treatment, the sizes of CNV volumes were compared in WT mice and IL-17 KO mice (n = 10-15). Representative CNV lesions of choroidal flat mounts are shown. Arrowheads indicate stained CNV tissues. Scale bars, 100 mm. (C) rIL-17 (0.5, 1, or 10 ng/ml; 2 ml) was inoculated into the vitreous cavities of WT mice immediately after laser treatment (n = 10-15). On day 7 after laser treatment, the sizes of CNV areas were compared among each group. The experiments were repeated three times, with similar results. Data are mean 6 SE. *p , 0.01. (D) vegf mRNA levels were compared in laser-treated WT and IL-17 KO mice at several time points (n = 3). The experiments were repeated three times, with similar results. Data are mean 6 SE. *p , 0.05. (E) WT mice were inoculated with control IgG (10 ng/ml; 2 ml), anti-IL-17 Ab (2 ml, left panel), anti-VEGF Ab (2 ml, right panel) into the vitreous cavities immediately after laser treatment (n = 10-15). On day 7 after laser treatment, the sizes of CNV volumes were compared (Figure legend continues) Ab (Fig. 1E, 1F) . The combination of anti-VEGF and anti-IL-17 Abs was more effective than was the administration of either Ab alone (Fig. 1F) . These data indicate that IL-17 has a strong potential for promoting neovascularization in a VEGF-independent manner in experimental CNV.
Although volume measurement by confocal microscopy was more sensitive than area measurement by conventional fluorescent microscopy, essentially similar effects were observed using these two methods (Fig. 1F) . Thus, we primarily used area measurement in later experiments because of the convenience of fluorescence microscopy.
Infiltrated gdT cells and ILCs are the main source of IL-17 in the laser-treated eye IL-17 was shown to be secreted not only from Th17 cells but also from innate immune cells (14) , gdT cells (21), and invariant NKT (iNKT) cells (22) . Based on these reports, we performed intracellular staining to investigate which cells produce IL-17 in the laser-treated eye. The number of IL-17 + cells increased after laser treatment ( Fig. 2A, upper were included, suggesting a mixture of heterogeneous populations.
Immunohistochemical analysis of retina and RPE/choroid sections revealed that gdT cells infiltrated into laser-injury lesions in the choroid regions (Fig. 2C) . Furthermore, IL-17-producing gdT cells were completely absent in the laser-treated eyes of mice lacking RORgt, a master transcription factor for IL-17 transcription (23, 24) (Fig. 2D) . These results indicate that infiltrating gdT cells are the main source of IL-17 in the eye after laser treatment. To clarify the importance of infiltrating gdT cells in CNV development, we examined TCRgd KO mice and found that their Il17a mRNA expression levels, as well as their IL-17 + cell counts, were significantly lower than those in WT mice (Fig. 2E, 2F ). The areas of CNV after laser treatment were smaller in TCRgd KO mice than in WT mice (Fig. 2G) . Although not statistically significant, administration of Ab against IL-17 always decreased the size of CNV areas in TCRgd KO mice or Rag2-deficient mice, suggesting a small contribution of IL-17-producing ILCs to CNV formation (Fig. 2G , data not shown for Rag2 2/2 mice). Adoptive transfer of T lymphocytes into Rag2-deficient (rag2KO) mice confirmed that gdT cells, but not conventional CD4 + T cells, were the major producers of IL-17 and that they greatly contributed to ocular neovascularization after laser injury (Fig. 2H) . These data suggest that IL-17, as well as IL-17-producing cells, could be therapeutic targets in the treatment of CNV. In addition, targeting the mechanism of IL-17 production in the injured eye could be a useful means of preventing CNV.
IL-
Next, we investigated which innate cytokines induce IL-17 from gdT cells, because targeting the mechanism of IL-17 production in the injured eye could be a useful means of preventing CNV. IL-23 was reported to be indispensable in the proliferation of these cells and in their ability to produce IL-17 (25, 26) . However, to our surprise, the degree to which CNV areas developed in IL-23p19 KO mice was identical to or only slightly less than that seen in WT mice (Fig. 3A) . IL-17 + gdT cells, as well as Il17a mRNA, were present in the IL-23p19 KO mice, although IL-17 levels were slightly lower in these mice than in WT mice (Fig. 3B, 3C) . These results suggest that IL-23 plays a limited role in IL-17 induction, and there is an IL-23-independent mechanism that stimulates IL-17 production from gdT cells.
Because IL-1b was shown to play a crucial role in inducing IL-17 production in vivo (26), we investigated its role next. IL1b was shown to be rapidly upregulated in laser-induced CNV (8) . We noticed that Il1b mRNA levels in the CNV regions were higher in IL-23p19 KO mice than in WT mice (data not shown), suggesting that IL-1b may be more important than IL-23 in the laser-induced CNV model. To test this, we blocked the effect of IL-1b using an IL-1R antagonist (IL-1ra). Consistent with the results of a previous report (8) , treatment of mice with IL-1ra reduced the size of the CNV areas in both WT and IL-23p19 KO mice (Fig. 4A) . IL-1ra treatment also reduced Il17a mRNA levels and the number of IL-17-producing cells in both WT and IL-23p19 KO mice (Fig. 4B, 4C ). The number of IL-17-producing cells was not significantly different between WT and IL-23 KO mice, although we always observed some reduction of IL-17 + cells in IL-23 KO mice. Furthermore, IL-1b potently induced IL-17 production from gdT cells more efficiently than did IL-23 in vitro (Fig. 4D) . These data indicate that IL-1b, rather than IL-23, plays more important roles in the induction of IL-17-producing gdT cells, as well as laser-induced CNV formation in the eye.
HMGB-1 as an inducer of IL-1b from macrophages and IL-17 from gdT cells
Given that IL-1b was shown to be mostly produced from macrophages (27), we investigated the endogenous TLR ligand that can induce macrophages to produce IL-1b. We confirmed that CNV areas were smaller in TLR2-and TLR4-deficient mice than in WT mice (Fig. 5A) . HMGB-1 was reported to be involved in Th17 development in an experimental autoimmune encephalomyelitis model (28) and to play important roles in alkalineinduced corneal neovascularization through TLR4 (29) . We observed that HMGB-1 also upregulated IL-17 secretion from gdT cells in collaboration with IL-1b (Fig. 4D) . Thus, we investigated the role of HMGB-1 in IL-17 induction in our laserinduced CNV model. HMGB-1 proteins are usually contained in the nucleus but can be released into the extracellular milieu as the result of injury or other forms of stress (30) . In the retina, degenerated photoreceptors exhibit augmented HMGB-1 expression after retinal detachment (31) . HMGB-1 mRNA expression was increased soon after laser exposure (Fig. 5B) . HMGB-1 ex- pression was induced in RPE and photoreceptor cells at the laserinjured choroid (Fig. 5C ). An Ab against HMGB-1 reduced the size of CNV areas (Fig. 5D) , as well as the rate of infiltration of IL-17 + gdT cells (Fig. 5E ). HMGB-1 blockade reduced IL-1b production (Fig. 5F ). Furthermore, rHMGB-1 induced IL-1b in a RAW macrophage cell line (Fig. 5G) . Taken together, these findings indicate that injured photoreceptor cells express damage-associated molecular pattern molecules (DAMPs), including HMGB-1, which results in the induction of IL-1b, which, in turn, promotes IL-17 secretion from gdT cells. HMGB-1 may also directly stimulate IL-17 production from gdT cells in collaboration with IL-1b, because gdT cells were reported to respond to TLR ligands (32) . As expected, rHMGB-1 upregulated IL-17 levels in gdT cells in vitro in the presence of IL-1b (Fig. 4D) . Thus, reducing patients' levels of IL-1b or HMGB-1, similar to a reduction in IL-17 level, might be an effective strategy for the prevention of CNV (Fig. 6 ).
Discussion
The laser-induced CNV mouse model is well established for investigating ocular angiogenesis (33) . As with human AMD, suppression of angiogenesis by an anti-VEGF Ab is therapeutic for laser-induced CNV (18) . This model system is eminently useful for identifying promising therapeutic targets for human AMD. For example, Takeda et al. (34) identified CCR3, a receptor found on eosinophils and mast cells, which are immune mediators of allergic inflammation, as an essential chemokine receptor for the growth of choroidal vessels in CNV. They demonstrated that blockade of intraocular CCR3 with neutralizing Abs or receptor antagonists significantly decreased the generation of abnormal blood vessels in the choroid after laser injury in a CNV mouse model. CCR3 was shown to be expressed in the endothelial cells lining the abnormal blood vessels of CNV in wet AMD patients, suggesting that the eotaxin-CCR3 axis is functional in human disease.
In the current study, we demonstrated that IL-17 plays an important role in promoting ocular neovascularization, and gdT cells, as well as a small fraction of ILCs, are the main sources of IL-17 in this laser-injury model. A recent study showed that IL-17 and IL-22 are elevated in the sera of AMD patients and that C5a promotes the production of these cytokines from human CD4 + T cells (15) . In our experimental CNV mouse model, gdT cells, rather than Th17 cells, were the major (∼70%) source of IL-17. Another recent study showed that gdT cells express a C5a receptor and promote IL-17 production by C5a stimulation (35) . However, because laser-induced CNV is an acute-injury model, the role of C5a in this system remains to be clarified.
Interestingly, VEGF levels were not affected by IL-17 deficiency (Fig. 1D) . This suggests that IL-17 functions as a proangiogenic factor in a VEGF-independent manner, and anti-IL-17 therapy could be useful for patients resistant to anti-VEGF therapy. Moreover, a combined therapy aimed at these two experiments were repeated three times with similar results. Data are mean 6 SE. *p , 0.01. (G) On day 7 after laser treatment, the sizes of CNV areas were evaluated and compared among WT mice, IL-17 KO mice, TCRgd KO mice, and TCRgd KO mice with Ab to IL-17 (10 ng/ml; 2 ml) inoculation into the vitreous cavities immediately after laser treatment (n = 10-15). Data are mean 6 SE. The experiment was repeated three times with similar results. Arrowheads indicate stained CNV tissues. Scale bars, 100mm. *p , 0.01. (H) A total of 3 3 10 5 CD3 + CD4 2 TCRgd + cells from WT mice or 1 3 10 6 CD3 + CD4 + TCRgd 2 cells from WT mice, purified by means of flow cytometry, were injected i.v. into Rag2 KO mice. At 4 d after cell transfer, the mice were subjected to laser treatment. On day 7 after laser treatment, eyes were enucleated for evaluation of CNV. Arrowheads indicate stained CNV tissues. Scale bars, 100mm. *p , 0.01. GCL, Ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer. The expression levels of IL17a mRNA in laser-treated eyes from WT mice, IL-23p19 KO mice, and TCRgd KO mice were monitored using real-time PCR on day 4 after laser treatment, and the data were normalized to HPRT levels (n = 3). *p , 0.01. (C) Ocular-infiltrating cells of WT mice (upper panels) and IL-23p19 KO mice (lower panels) were analyzed on day 4 after laser treatment (n = 2). Results of gating for CD3 (left panels) and TCRgd + (right panels) cells are shown for each eye sample. The production of IL-17A in cells was examined by intracellular staining (right panels). One representative experiment of three independent experiments is shown.
cytokines may be more powerful than a single-treatment approach. Although there are a number of reports suggesting that IL-17 promotes angiogenesis by directly stimulating endothelial cells, the precise mechanism of angiogenesis by IL-17 is not clear. Other reports indicate that VEGF is induced by IL-17 (11) . Thus, we could not completely rule out the possibility that VEGF induced by IL-17 participates in CNV formation in WT animals (Fig. 6) . In addition to gdT cells, we found that 30% of IL-17 came from CD3
2 Thy1 + ILCs. In this fraction, both Sca1 + and Sca1 2 cells were included; therefore, a mixture of heterogeneous populations is likely. However, IL-17 production was completely dependent on RORgt. Because IL-17-producing ILCs are reported as being mostly present in the gut (36) , the origin of IL-17 + ILCs in the eye is an intriguing subject. We showed that iNKT cells also play a role in CNV angiogenesis (6), but we could exclude the possibility that IL-17 + ILCs were iNKT cells because those cells were CD3
2 .
Another important feature of IL-17 production in the eye is the need for IL-23. IL-23 was reported to play critical roles in IL-17 production from conventional Th17 and gdT cells (26) . For example, IL-17 production from Th17 cells and gdT cells infiltrated into the brain was completely dependent on IL-23 in an experimental autoimmune encephalomyelitis model and a brain ischemia model, respectively (17, 21) . IL-23 was shown to be a potent inducer of inflammation in autoimmune diseases, RA, psoriasis, encephalomyelitis, and inflammatory bowel diseases. However, in our current study, we demonstrated that gdT cells can produce IL-17 without IL-23 (Fig. 3) . With regard to Th17 cells, TGF-b plus IL-6 was shown to be necessary for early development of Th17 in vitro, and IL-23 is not necessary for early Th17 cell development in vitro, but it appears to be required for pathogenic features of Th17 cells. Izcue et al. (37) reported that TGF-b, rather than IL-23, was essential for Th17 development in vivo. However, it was shown that IL-23 is the most potent inducer of IL-17 from gdT cells. We examined other reported IL-17-inducing factors, including bacterial TLR ligands, as well as IL-6, and found that only IL-1b can act as a substitute for IL-23 in inducing IL-17 secretion from gdT cells (Fig. 4) . In AMD patients, it was reported that accumulated macrophages in CNV areas and RPE cells secrete IL-1b (27) . In mouse models, macrophages also infiltrate the eye (5), and IL-1b expression increases soon after laser treatment (8) . Thus, we suspected that IL-1b is an essential factor in the induction of IL-17 from gdT cells, but we could not rule out other factors that stimulate TLRs. For example, we reported that Chlamydia pneumonia infection enhances CNV via TLR2 (38) .
Because the laser CNV model is dependent on TLR2/4, we suspected that certain TLR ligands might stimulate IL-1b production from macrophages. However, no bacterial infection was evident in our laser-induced models; thus, endogenous DAMPs could be candidates. HMGB-1 protein, heat shock proteins, b-amyloid, and others were reported to be endogenous ligands for TLR and to function as DAMPs (39, 40) . A recent study suggests that drusen components activate NLRP3, which induces IL-18, although drusen alone does not seem to activate TLRs (41) . We investigated HMGB-1 because rHMGB-1, but not other recombinant proteins, including peroxiredoxins (42), potently induces IL-1b from macrophagelike cells. Secretion of IL-1b requires inflammasome activation, as well as TLR stimulation, and HMGB-1 seems to be able to activate both pathways simultaneously. The mechanism of inflammasome activation by HMGB-1 remains to be clarified. Our data indicated the possibility that HMGB-1 proteins play specific roles at different phases after laser injury. HMGB-1 mRNA levels increased rapidly after laser injury (Fig. 5B) . Thus, early HMGB-1 may induce IL-1b from macrophages on day 1, which is consistent with the time course of IL-1b mRNA expression. We also noticed maintained HMGB-1 protein expression in the laser-injured choroid on day 4 (Fig. 5C) . We showed that HMGB-1 stimulated IL-17 production in combination with IL-1b from gdT cells. Thus, HMGB-1 protein may enhance IL-17 production from infiltrated gdT cells in a late phase after laser injury.
Apparently, IL-1b is proangiogenic, whereas Doyle et al. (41) showed that IL-18 is antiangiogenic, indicating that IL-1b and IL-18 have opposite functions in CNV formation. Doyle et al. (41) reported that LPS and the complement factor C1Q induced IL-1b at higher levels than IL-18 in vitro, and IL-1b mRNA expression was elevated from a few hours after laser stimulation in the laser-induced CNV model (8) . We suspect that, in the early phase of injury, CNV is promoted by the NLRP3-IL-1b pathway, which is activated by strong DAMPs like HMGB-1, whereas, in a late phase, CNV is suppressed by the NLRP3-IL-18 pathway, which is activated by unknown DAMPs to promote tissue repair and remodeling or to maintain the choroidal homeostasis. Because little is known about the induction mechanisms of IL-1b and IL-18, the significance of these two related cytokines in CNV formation remains to be investigated.
The elevated IL-17 levels in the sera (15) suggest that increasing levels of IL-17 in the eye may be involved in the pathogenesis of AMD. Because humanized anti-IL-17 Ab is now in phase II trials for RA and psoriasis, anti-IL-17 therapy may become easily and rapidly applicable for AMD patients. We also expect that the suppression of innate cell activators, such as IL1b and HMGB-1, could be preventive against the development of human AMD.
three times with similar results. Data are mean 6 SE. *p , 0.01. (F) Total RNA was extracted from the eyes of WT mice, with or without Ab to HMGB-1 inoculation into the vitreous cavities immediately after laser treatment, on day 1 after laser treatment (n = 3). Il1b mRNA levels were normalized to HPRT levels in each sample. *p , 0.01. (G) RAW cells (2 3 10 5 ) were treated or not with 1 mM rHMGB-1 for 24 h. The expression levels of Il1b mRNA were monitored using real-time PCR, and the data were normalized to HPRT levels (n = 3). IL-1b protein levels in the culture supernatant were determined by ELISA. *p , 0.01. 
